Request Demo
Recent blog posts
Latest Hotspot
10 min read
Obstructive azoospermia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Obstructive azoospermia strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Pelvic adhesions Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Pelvic adhesions indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
Mira Pharmaceuticals Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Mira Pharmaceuticals Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Hydrosalpinx Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Hydrosalpinx indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
8 min read
MimiVax, LLC Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
MimiVax, LLC BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Endometrial polyps Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
Explore the 2026 Endometrial polyps indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Vaginal intraepithelial neoplasia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vaginal intraepithelial neoplasia strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Chronic endometritis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Chronic endometritis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
8 min read
miRecule, Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
miRecule, Inc. BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.
Latest Hotspot
10 min read
Pelvic inflammatory disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Pelvic inflammatory disease strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Vulvar intraepithelial neoplasia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
5 August 2026
2026 Vulvar intraepithelial neoplasia strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
8 min read
Moberg Pharma Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
5 August 2026
Moberg Pharma BD opportunity scan covering pipeline ownership, development stage, evidence package, IP risk, deal precedent and outreach rationale using PatSnap MCP.